Related content

Impact of the UGT1A1*28 allele on response to irinotecan: a systematic review and meta-analysis

By Dias Mafalda M   McKinnon Ross A   Sorich Michael J  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 889-899

Future Medicine

Access to resources Recommend Favorite

UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine

By Goetz Matthew   McKean Heidi   Reid Joel   Mandrekar Sumithra   Tan Angelina   Kuffel Mary   Safgren Stephanie   McGovern Renee   Goldberg Richard   Grothey Axel   McWilliams Robert   Erlichman Charles   Ames Matthew  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1559-1567

Springer Publishing Company

Access to resources Recommend Favorite

UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 3, 2015-06 ,pp. : 219-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

ABCB1, SLCO1B1 and UGT1A1 Gene Polymorphisms Are Associated with Toxicity Line Irinotecan

By  

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 23-30

Bentham Science Publishers

Access to resources Recommend Favorite

Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism

By Font Albert   Sánchez José Miguel   Tarón Miquel   Martinez-Balibrea Eva   Sánchez José Javier   Manzano José Luis   Margelí Mireia   Richardet Martin   Barnadas Agustí   Abad Albert   Rosell Rafael  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 435-443

Springer Publishing Company

Access to resources Recommend Favorite